A blood thinner used by millions of people was praised for healing the heart. Now, that study has been retracted and investigations into potentially fraudulent research are expanding.
Xarelto (rivaroxaban) is a blockbuster blood thinning medication that’s been prescribed more than 80 million times in the U.S. alone
The drug may have been approved based on manipulated data, including a now-retracted paper by Temple University researchers that concludedXarelto“could have a healing effect on hearts”
The Journal of Molecular and Cellular Cardiology and the Journal of Biological Chemistry are investigating five more Xarelto papers by the Temple University team
The U.S. Office of Research Integrity (ORI)also requested in September 2020 that Temple University investigate a number of Xarelto research studies
As a result, Temple University is looking into 15 Xarelto papers published from 2008 to 2020, which received grant money from the U.S. National Institutes of Health
Xarelto (rivaroxaban) is a blockbuster blood thinning medication that’s been prescribed more than 80 million times in the U.S. alone. But the drug, which is manufactured by the Janssen Pharmaceuticals division of Johnson & Johnson, may have been approved based on manipulated data….
Source: The Epoch Times